Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESA.

Scientific reports | 2023

Despite the prognostic value of arterial stiffness (AS) and pulsatile hemodynamics (PH) for cardiovascular morbidity and mortality, epigenetic modifications that contribute to AS/PH remain unknown. To gain a better understanding of the link between epigenetics (DNA methylation) and AS/PH, we examined the relationship of eight measures of AS/PH with CpG sites and co-methylated regions using multi-ancestry participants from Trans-Omics for Precision Medicine (TOPMed) Multi-Ethnic Study of Atherosclerosis (MESA) with sample sizes ranging from 438 to 874. Epigenome-wide association analysis identified one genome-wide significant CpG (cg20711926-CYP1B1) associated with aortic augmentation index (AIx). Follow-up analyses, including gene set enrichment analysis, expression quantitative trait methylation analysis, and functional enrichment analysis on differentially methylated positions and regions, further prioritized three CpGs and their annotated genes (cg23800023-ETS1, cg08426368-TGFB3, and cg17350632-HLA-DPB1) for AIx. Among these, ETS1 and TGFB3 have been previously prioritized as candidate genes. Furthermore, both ETS1 and HLA-DPB1 have significant tissue correlations between Whole Blood and Aorta in GTEx, which suggests ETS1 and HLA-DPB1 could be potential biomarkers in understanding pathophysiology of AS/PH. Overall, our findings support the possible role of epigenetic regulation via DNA methylation of specific genes associated with AIx as well as identifying potential targets for regulation of AS/PH.

Pubmed ID: 37848499 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00005
  • Agency: NHGRI NIH HHS, United States
    Id: U54 HG003067
  • Agency: NIA NIH HHS, United States
    Id: K24 AG070459
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00007
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95167
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000040
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001881
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00002
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201500003C
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95160
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL120393
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL155599
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95163
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001079
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL155764
  • Agency: NCATS NIH HHS, United States
    Id: U01 TR003734
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00001
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95169
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL153248
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL157108
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95164
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL104106
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95162
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00003
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL105756
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95168
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95165
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95159
  • Agency: NIA NIH HHS, United States
    Id: R01 AG058969
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95161
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001420
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00004
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL153646
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL160277
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201500003I
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL117626
  • Agency: NHLBI NIH HHS, United States
    Id: 75N92020D00006
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC95166
  • Agency: NHLBI NIH HHS, United States
    Id: R33 HL146390

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Gene Set Enrichment Analysis (tool)

RRID:SCR_003199

Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.

View all literature mentions

KEGG (tool)

RRID:SCR_012773

Integrated database resource consisting of 16 main databases, broadly categorized into systems information, genomic information, and chemical information. In particular, gene catalogs in completely sequenced genomes are linked to higher-level systemic functions of cell, organism, and ecosystem. Analysis tools are also available. KEGG may be used as reference knowledge base for biological interpretation of large-scale datasets generated by sequencing and other high-throughput experimental technologies.

View all literature mentions

Genotype-Tissue Expression (tool)

RRID:SCR_013042

Project to study human gene expression and regulation in multiple tissues, providing valuable insights into mechanisms of gene regulation and its disease related perturbations. Genetic variation between individuals will be examined for correlation with differences in gene expression level to identify regions of the genome that influence whether and how much a gene is expressed. Includes initiatives: Novel Statistical Methods for Human Gene Expression Quantitative Trait Loci (eQTL) Analysis ,Laboratory, Data Analysis, and Coordinating Center (LDACC), caHUB Acquisition of Normal Tissues in Support of GTEx Project.

View all literature mentions